Arkolith/Insider Trading/CLVS/Form 4

Harding Thomas C.

See RemarksClovis Oncology, Inc. (CLVS) · full profile →Form 4 · filed Oct 4, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8
Net Open-Market Flow
-$8
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 3, 2022Sell(S)6$1.29$84K
Oct 1, 2022Option exercise(M)15——4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 1, 2022Option exercise(M)15—$0109

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-032655) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML